Search Results 1571-1580 of 16345 for monoclonal antibody

1. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

   Subjects with a positive test for Hepatitis C (HCV) antibody are excluded, regardless of viral load. If hepatitis C antibody is positive, confirmatory tests may ...

2. Model Clarifies Immunotherapy for Multiple Myeloma - Mayo Clinic News Network

   Bispecific-T-cell-engaged-antibodies immunotherapy is similar to a treatment where the patient's T cells are collected, genetically altered to "see" their ...

3. A Study of X4P-001 in Patients with Advanced Renal Cell Carcinoma - Mayo Clinic

   An indeterminate or positive test for antibody to human immunodeficiency virus (HIV-1 or -2) ... Other chemotherapy (e.g., mitomycin-C, nitrosourea) or ...

4. High blood protein When to see a doctor - Mayo Clinic

   https://www.niddk.nih.gov/health-information/kidney-disease/amyloidosis. Accessed Oct. 28, 2022. Monoclonal gammopathies of undetermined significance (MGUS).

5. Patient Stories - Andrew McKeon, M.B., B.Ch., M.D. - Mayo Clinic

   Patient Stories · Comprehensive testing leads to targeted treatment for rare autoimmune encephalitis antibody · Specialized testing helps reverse effects of stiff ...

6. Overview - T Cell Engineering Laboratory - Mayo Clinic Research

   A chimeric antigen receptor is a synthetic antibody on the surface of T cells that enables T cells to recognize cancer cells. The most successful CAR -T ...

7. Mayo Clinic researchers question effectiveness of mRNA COVID-19 vaccines for solid organ transplant patients

   Wadei and his team tested the blood of patients who had received a solid organ for spike antibodies to COVID-19, which would be the type of antibody generated ...

8. Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome - Mayo Clinic

   - Absent or low patient donor-specific antibodies (DSA); - Mean fluorescence intensity (MFI) of any anti-donor HLA antibody by solid phase immunoassay ...

9. A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   ... antibody therapy is allowed regardless of the prior treatment settings. For Phase II, Arms 1 and 2, prior cetuximab or other EGFR-targeted antibody ...

10. Efficacy and Safety of ISIS-TTR Rx in Familial Amyloid Polyneuropathy - Mayo Clinic

    Known monoclonal gammopathy of undetermined significance or multiple myeloma; Other causes of sensorimotor or autonomic neuropathy (e.g., autoimmune disease) ...